4/27
04:28 am
rprx
A Look At Royalty Pharma (RPRX) Valuation After Its Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Look At Royalty Pharma (RPRX) Valuation After Its Recent Share Price Momentum [Yahoo! Finance]
4/22
05:07 pm
rprx
Biogen (BIIB) Q4 2024 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]
Low
Report
Biogen (BIIB) Q4 2024 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]
4/22
04:50 pm
rprx
Agios (AGIO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Agios (AGIO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
4/21
01:00 pm
rprx
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
Low
Report
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
4/21
08:08 am
rprx
Royalty Pharma (RPRX) had its "buy" rating reaffirmed by UBS Group AG.
Low
Report
Royalty Pharma (RPRX) had its "buy" rating reaffirmed by UBS Group AG.
4/19
08:23 pm
rprx
Why Royalty Pharma Plc (RPRX) is One of the Most Undervalued Biotech Stocks to Buy Right Now [Yahoo! Finance]
Low
Report
Why Royalty Pharma Plc (RPRX) is One of the Most Undervalued Biotech Stocks to Buy Right Now [Yahoo! Finance]
4/17
08:47 am
rprx
Royalty Pharma Declares Second Quarter 2026 Dividend [Yahoo! Finance]
Low
Report
Royalty Pharma Declares Second Quarter 2026 Dividend [Yahoo! Finance]
4/17
08:30 am
rprx
Royalty Pharma Declares Second Quarter 2026 Dividend
Low
Report
Royalty Pharma Declares Second Quarter 2026 Dividend
4/15
04:15 pm
rprx
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
Low
Report
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
4/10
12:05 pm
rprx
Royalty Pharma (RPRX) was given a new $63.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.
Low
Report
Royalty Pharma (RPRX) was given a new $63.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.
4/5
01:34 pm
rprx
Assessing Royalty Pharma (RPRX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Royalty Pharma (RPRX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
4/3
12:26 pm
rprx
1 Value Stock for Long-Term Investors and 2 Facing Challenges [Yahoo! Finance]
Low
Report
1 Value Stock for Long-Term Investors and 2 Facing Challenges [Yahoo! Finance]
4/1
09:48 pm
rprx
Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal [Yahoo! Finance]
Low
Report
Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal [Yahoo! Finance]
3/31
08:33 am
rprx
1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm [Yahoo! Finance]
Medium
Report
1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm [Yahoo! Finance]
3/30
09:26 am
rprx
Royalty Pharma and J&J partner to develop autoimmune treatment [Yahoo! Finance]
Low
Report
Royalty Pharma and J&J partner to develop autoimmune treatment [Yahoo! Finance]
3/30
07:15 am
rprx
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
Low
Report
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
3/27
09:42 am
rprx
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update [Yahoo! Finance]
Low
Report
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update [Yahoo! Finance]
3/23
07:15 am
rprx
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
Low
Report
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
3/21
05:24 pm
rprx
How The Royalty Pharma (RPRX) Story Is Shifting With New Deals And Updated Expectations [Yahoo! Finance]
Low
Report
How The Royalty Pharma (RPRX) Story Is Shifting With New Deals And Updated Expectations [Yahoo! Finance]
3/17
04:43 pm
rprx
Royalty Pharma Announces Expansion of Leadership Team [Yahoo! Finance]
Low
Report
Royalty Pharma Announces Expansion of Leadership Team [Yahoo! Finance]
3/17
04:01 pm
rprx
Royalty Pharma Announces Expansion of Leadership Team
Low
Report
Royalty Pharma Announces Expansion of Leadership Team
3/3
07:33 pm
rprx
Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]
Low
Report
Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]
3/3
03:57 pm
rprx
Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Neutral
Report
Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/3
05:32 am
rprx
Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule [Yahoo! Finance]
Low
Report
Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule [Yahoo! Finance]
3/2
09:15 pm
rprx
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
Low
Report
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform